Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / cephalosporins / neurontin attending: chief complaint: bilateral pulmonary emboli and copd flare major surgical or invasive procedure: none history of present illness: 74 yo male nh resident, h/o copd (on o2), type 2 dm, presenting with lethargy, hypoglycemia, and sob; pt was 83-84% with fsbg=59. pt improved with dextrose, o2, and sat's went up to 91%. given pt's lethargy, hct was performed which was negative for mass effect or bleed. cxr on admission showed possible rul/rml pna, but was concerning for endobronchial lesion. f/u chest ct showed bilateral pe's, and patient was started on anticoagulation with coumadin and lovenox. pt's vitals o/w stable. pt was on prednisone taper on admission and got stress-dose solumedrol in ed. pt was initially stable on the floor, but on hospital day , he had an acute desaturation, was working hard to breathe/using accessory muscle, and was transferred to the micu at this time where he was stabilized using non-invasive measures (o2 mask, frequent nebs). pt transferred back to floor when he was more stable from a respiratory standpoint. past medical history: pmh: copd-on o2, type 2 dm, mrsa, prostate cancer, diverticulitis, glaucoma, is legally blind, hypercholesterolemia. social history: sh: married, has been in a nh for the past 2-3 weeks after a recent hospital admission to , likely with mid. no etoh, former smoker, was dnr/dni in nursing home. family history: non-contributory physical exam: vs: 97.9 103 138/64 22 97% 4l gen: mild respiratory distress, pleasant, slightly disoriented, appropriate responses heent: dilated pupils (bland) cv: tachycardic s1/s2, no m/r/g lungs: prolonged expiratory phase, wheezing, rhonchi in right base abd: soft, nt/nd, no hsm, nabs extr: no edema/cyanosis/clubbing, dp and pt intact bilaterally neuro: grossly intact pertinent results: 03:00am pt-13.4* ptt-28.5 inr(pt)-1.2 03:00am plt smr-low plt count-144* 03:00am wbc-9.0 rbc-3.39* hgb-9.9* hct-33.0* mcv-97 mch-29.3 mchc-30.1* rdw-15.4 03:00am glucose-196* urea n-11 creat-0.7 sodium-143 potassium-3.7 chloride-103 total co2-35* anion gap-9 brief hospital course: 1. severe b pe. pt was initially put on lovenox 70 with coumadin when pe's discovered on chest ct. pt was stable for 2 days and then had an acute episode of desaturation, o2 sats 83-84% on 4l, minimal improvement with nebs and 50% facemask. chest x-ray did not show any acute process, but patient was laboring to breathe, using accessory muscles, and was not moving air very well. abg showed some co2 retention, a normal ph, but inadequate o2 sat given the amount of facemask o2. he was transferred to the micu at this time where he was managed and stabilized without intubation (frequent nebs, o2). tte showed possible left mobile pa mass/clot; suggestion was patient was throwing new clots even though on lovenox. pt started on heparin drip, became more stable from a respiratory standpoint, and he was transferred back to the floor where he has remained stable on 2 l nc o2, nebs, hep gtt, antibiotics, and steroid taper. heparin was discontinued after 48 hour overlap (therapeutic on both coumadin and heparin), and patient discharged on coumadin for lifelong anticoagulation. ivc filter should be considered if this anticoagulation is inadequate. 2. copd: pt continued on a prednisone taper (2wks) for possible copd flare, likely one of the reasons for his respiratory distress. pt also with frequent nebs and o2 as needed (pt has baseline 2 l o2 requirement). 3. ?pna-normal cxr, afebrile, but did have bandemia on admission and now with pseudomonas in sputum, resistent to quinolones. given allergy to pcn, ceph, wills start aztreonam for presumptive coverage since he has poor respiratory status. 14-d course of aztreonam with a 7-day course of levo for possible pneumonia with copd flare. 4. dm- restart 70/30 at 1/2 dose; will cover with ssi, and cked fsbg in house. 5. psych: continue effexor, give ambien for insomnia; hold xanax, monitor for signs of benzo withdrawal 6. fen- gave boluses as necessary, no standing ivf 7. ppx- zantac, mrsa precautions 8. pt is now full code; reversed code status in-house given possibly reversible cause of respiratory distress. this should be reviewed upon return to rehab facility, for patient was dnr/dni prior to this admission. medications on admission: prednisone 30 mg (taper) humulin 70/30, 55 qam, 28 qpm trisoptin drops alphagen drops colace albuterol xanax 0.25 tid sq heparin flutamide 250 tid kcl zantac 150 effexor 75 qd verapamil 120 tid ambien 10 mg qhs vit c discharge medications: 1. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours). 2. albuterol sulfate 0.083 % solution sig: one (1) inhalation q2h (every 2 hours) as needed. 3. dorzolamide hcl 2 % drops sig: one (1) drop ophthalmic (2 times a day). 4. brimonidine tartrate 0.2 % drops sig: one (1) drop ophthalmic (2 times a day). 5. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po qd (once a day). 6. flutamide 125 mg capsule sig: two (2) capsule po tid (3 times a day). 7. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). 8. venlafaxine hcl 75 mg tablet sig: one (1) tablet po qd (once a day). 9. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 10. acetaminophen 325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. 11. zolpidem tartrate 5 mg tablet sig: one (1) tablet po hs (at bedtime) as needed. 12. albuterol-ipratropium 103-18 mcg/actuation aerosol sig: puffs inhalation q6h (every 6 hours). 13. warfarin sodium 5 mg tablet sig: one (1) tablet po qd (once a day). 14. verapamil hcl 120 mg tablet sig: one (1) tablet po q8h (every 8 hours). 15. prednisone 20 mg tablet sig: three (3) tablet po qd (once a day) for 13 days: take 60 mg until , take 40 mg until , take 20 mg until , then off. disp:*23 tablet(s)* refills:*0* 16. insulin 70/30 70-30 unit/ml suspension sig: 25 u subcutaneous qac. 17. insulin 70/30 70-30 unit/ml suspension sig: 15 u subcutaneous at bedtime. 18. levofloxacin 500 mg iv q24h duration: 1 days continue until 19. aztreonam mg iv q8h duration: 11 days continue until discharge disposition: extended care facility: hospital discharge diagnosis: bilateral pulmonary emboli, copd flare discharge condition: good discharge instructions: please let staff at acute rehab know if you are experiencing chest pain, shortness of breath, fevers, chills, or any other concerns. 1. pt needs monitoring of his coumadin; pt found to have bilateral severe pe's on chest ct, thought to be chronic. he will need lifelong anticoagulation with coumadin. his goal inr is . he will need an inr ck in the morning of ; pt currently on 5mg coumadin each day. if lifelong anticoagulation proves to be inadequate, an ivc filter should be considered. 2. pt was dnr/dni before this hospitalization; code status was reversed given the possibly reversible nature of his pulmonary emboli. this should be rediscussed; it is reasonable to resume patient's prior code status. 3. pt has a relatively new diagnosis of dementia (from last 1-2 months). followup instructions: will have f/u at rehabilitation facility need inr checks regularly for coumadin therapy procedure: venous catheterization, not elsewhere classified diagnoses: unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other pulmonary insufficiency, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation other pulmonary embolism and infarction 

Answer: The patient is high likely exposed to